Zepbound vs Mounjaro: Same Medication, Different Uses

Zepbound and Mounjaro both contain tirzepatide at the same doses. Here is what actually differs: what each is approved for, who can get it covered, and whether you can switch.

Key points

  • Zepbound and Mounjaro are the same medication: tirzepatide, a once-weekly injection from Eli Lilly.
  • Zepbound is approved for weight management and obstructive sleep apnea. Mounjaro is approved for type 2 diabetes.
  • Doses, schedule, side effects and storage are the same.
  • The label says not to use them together.

If you have seen both names and wondered which one is "better", the short answer is that they are the same drug in two boxes. The brand you are prescribed depends on why you are taking it.

Side by side

ZepboundMounjaro
Active ingredientTirzepatideTirzepatide
MakerEli LillyEli Lilly
Approved forReducing excess body weight and keeping it off in adults with obesity, or overweight with a weight-related condition; moderate to severe obstructive sleep apnea in adults with obesityBlood sugar control in type 2 diabetes in adults and children 10 and older; lowering the risk of major cardiovascular events in adults with type 2 diabetes at high risk
Strengths2.5, 5, 7.5, 10, 12.5, 15 mg2.5, 5, 7.5, 10, 12.5, 15 mg
How oftenOnce a weekOnce a week
FormsSingle-dose pen, single-dose vial, KwikPen, multi-dose vialSingle-dose pen, single-dose vial, KwikPen, multi-dose vial
Starting dose2.5 mg for 4 weeks2.5 mg for 4 weeks
Maximum dose15 mg weekly15 mg weekly for adults

What is actually different

The approved use. Zepbound is used together with a reduced-calorie diet and more physical activity for weight management, and to treat obstructive sleep apnea in adults with obesity. Mounjaro is used with diet and exercise for type 2 diabetes.

Insurance. This is where the brand name matters most. Plans usually cover Mounjaro for people with type 2 diabetes. Coverage of Zepbound for weight management varies widely from plan to plan. Check your own plan's rules before assuming either is covered.

The trials behind the label. Zepbound's weight results come from studies in people with obesity. In SURMOUNT-1, adults without diabetes lost an average of 15.0% of their body weight on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg over 72 weeks, compared with 3.1% on placebo. People with type 2 diabetes tend to lose somewhat less weight on the same doses.

What is the same

  • Dosing. Both start at 2.5 mg and rise in 2.5 mg steps, each after at least four weeks. See the dosing chart.
  • Missed dose. Take it within 4 days (96 hours); otherwise skip it. Doses must be at least 3 days apart.
  • Side effects. Mostly nausea, diarrhea, vomiting and constipation, with the same boxed warning about thyroid C-cell tumors. See Zepbound side effects.
  • Injection sites. Abdomen, thigh or the back of the upper arm, rotating with each dose.
  • Storage. In the fridge, or up to 21 days at room temperature for single-dose pens and vials. See Zepbound storage.

Slimsy works the same with Zepbound and Mounjaro. If your prescription changes from one to the other, your dose history stays in one timeline.

Try Slimsy

Can you switch between them?

People do move from one brand to the other, typically when a diagnosis, insurance plan or pharmacy supply changes. Because the medication and strengths are identical, a prescriber can usually continue the same dose, but that is their call to make. What you should not do is use both, or combine either with another GLP-1 medication. The Zepbound label states that this is not recommended.

Which one will I be prescribed?

If you have type 2 diabetes, Mounjaro is the brand approved for you. If you are being treated for obesity, overweight with a related condition, or sleep apnea with obesity, it is Zepbound. Your prescriber and your insurance plan decide the rest. Either way, the day-to-day routine is the same: one injection a week, on the same day, with a record of your dose and injection site.

Frequently asked questions

Is Zepbound the same as Mounjaro?

They contain the same active ingredient, tirzepatide, made by Eli Lilly, in the same strengths from 2.5 mg to 15 mg. The difference is what each brand is approved to treat.

Can I take Zepbound and Mounjaro together?

No. The Zepbound label says using it with other tirzepatide-containing products, or with any GLP-1 receptor agonist, is not recommended.

Can I switch from Mounjaro to Zepbound?

Because the medication and doses are the same, prescribers can move people from one brand to the other, usually for insurance or indication reasons. The decision and the dose are your prescriber's.

Which is better for weight loss, Zepbound or Mounjaro?

Neither is stronger, because they are the same medication. Zepbound is the brand approved for weight management, so it is the one prescribed and covered for that purpose.

Sources

  1. Zepbound (tirzepatide) prescribing information, DailyMed, revised August 2026
  2. Mounjaro (tirzepatide) prescribing information, DailyMed, revised August 2026
  3. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022

This article is general information, not medical advice. It was written by the Slimsy team from the sources listed above and has not been reviewed by a medical professional. Prescribing information changes; always follow the Medication Guide that comes with your prescription and your prescriber's instructions.